Inflammatory response time course, HUVEC (Wada, 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIX
|
ENSG00000008441.18 | NFIX |
NFIB
|
ENSG00000147862.17 | NFIB |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIB | hg38_v1_chr9_-_14300231_14300269 | 0.92 | 1.0e-10 | Click! |
NFIX | hg38_v1_chr19_+_12995467_12995500 | -0.69 | 1.2e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.3 | 9.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
2.0 | 6.1 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
2.0 | 8.0 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
2.0 | 5.9 | GO:0099557 | trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission(GO:0099557) |
1.9 | 5.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
1.8 | 5.4 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
1.8 | 5.4 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
1.7 | 5.2 | GO:0060003 | copper ion export(GO:0060003) |
1.6 | 4.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.5 | 8.9 | GO:0051585 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
1.4 | 4.2 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
1.4 | 8.3 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
1.3 | 4.0 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.3 | 3.9 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
1.3 | 3.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 6.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
1.1 | 2.3 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
1.1 | 4.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
1.0 | 3.1 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.0 | 3.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.0 | 3.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
1.0 | 4.1 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
1.0 | 4.1 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
1.0 | 4.0 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
1.0 | 4.0 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
1.0 | 2.9 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.9 | 0.9 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
0.9 | 2.8 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.9 | 2.8 | GO:0071810 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.9 | 3.7 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.9 | 8.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.9 | 3.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 2.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.8 | 5.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.8 | 8.4 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.8 | 9.1 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.8 | 3.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.8 | 3.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.8 | 2.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 2.4 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.8 | 2.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.8 | 2.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.8 | 11.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.8 | 6.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 6.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.8 | 2.3 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.7 | 2.2 | GO:1904437 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) cellular response to iron(III) ion(GO:0071283) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.7 | 2.2 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.7 | 3.0 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.7 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 2.2 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
0.7 | 0.7 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.7 | 2.1 | GO:0001300 | chronological cell aging(GO:0001300) |
0.7 | 2.1 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
0.7 | 5.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.7 | 2.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.7 | 6.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 2.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.7 | 1.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.7 | 2.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 2.6 | GO:0006272 | leading strand elongation(GO:0006272) |
0.6 | 3.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 1.9 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.6 | 3.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 2.5 | GO:0009956 | radial pattern formation(GO:0009956) |
0.6 | 5.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 2.5 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.6 | 3.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 1.8 | GO:0021593 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
0.6 | 1.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 3.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.6 | 4.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 3.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.6 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 1.8 | GO:0031247 | actin rod assembly(GO:0031247) |
0.6 | 1.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.6 | 3.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.6 | 7.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.6 | 2.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 2.9 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.6 | 0.6 | GO:1990641 | response to iron ion starvation(GO:1990641) |
0.6 | 6.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 2.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.5 | 4.4 | GO:0060025 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) |
0.5 | 2.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.1 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.5 | 5.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 3.7 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.5 | 1.6 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.5 | 1.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 3.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 4.1 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) regulation of opsonization(GO:1903027) |
0.5 | 1.5 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.5 | 1.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.5 | 4.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 1.5 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.5 | 2.5 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.5 | 1.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.5 | 0.5 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.5 | 2.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 9.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.5 | 1.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.5 | 2.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.5 | 2.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.5 | 4.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 1.4 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.5 | 1.9 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 10.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 1.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.5 | 1.8 | GO:0018032 | protein amidation(GO:0018032) |
0.5 | 4.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.5 | 1.4 | GO:0070429 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.5 | 2.3 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.5 | 3.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 2.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.4 | 0.9 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.4 | 2.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.4 | 0.9 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 1.3 | GO:0002194 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.4 | 3.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 1.7 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.4 | 5.2 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.4 | 4.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.4 | 1.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.4 | 1.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 2.1 | GO:0035645 | enteric smooth muscle cell differentiation(GO:0035645) |
0.4 | 1.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 1.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.4 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.4 | 0.8 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 4.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.4 | 1.2 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.4 | 1.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.4 | 0.4 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.4 | 2.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 5.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 2.0 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
0.4 | 3.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.4 | 1.2 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell differentiation(GO:0061443) endocardial cushion cell fate commitment(GO:0061445) |
0.4 | 1.5 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.4 | 12.4 | GO:0072189 | ureter development(GO:0072189) |
0.4 | 0.8 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.4 | 0.4 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.4 | 2.7 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.4 | 2.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 0.4 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.4 | 5.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 1.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.4 | 4.1 | GO:0015866 | ADP transport(GO:0015866) |
0.4 | 3.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.4 | 1.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.4 | 1.1 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.4 | 0.4 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.4 | 1.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.4 | 2.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 3.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.4 | 3.6 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 7.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.4 | 6.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 1.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 1.4 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.3 | 2.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 2.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.3 | 1.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.3 | 1.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.3 | 3.0 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.3 | 2.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 2.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 3.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.3 | 2.3 | GO:0033216 | ferric iron import(GO:0033216) |
0.3 | 2.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 1.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 2.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.3 | 0.9 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.3 | 0.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 2.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 0.9 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.3 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 0.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.3 | 5.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.9 | GO:1902955 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.3 | 0.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.3 | 3.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.3 | 1.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.3 | 0.6 | GO:0015853 | adenine transport(GO:0015853) |
0.3 | 0.3 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.3 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.3 | 0.6 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.3 | 1.7 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.9 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.3 | 0.6 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.3 | 0.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 2.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 2.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 1.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 4.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.8 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.3 | 1.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 1.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 1.1 | GO:0051257 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
0.3 | 0.8 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.3 | 2.7 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 2.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 0.8 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 1.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 3.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 0.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.3 | 0.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.3 | 0.8 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.3 | 3.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 2.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 7.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.3 | 0.5 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 0.8 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.3 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 4.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 2.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.3 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.3 | 1.0 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.3 | 0.8 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 1.0 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.3 | 1.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 1.8 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.3 | 1.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 2.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 0.7 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.2 | 2.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 1.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 1.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 0.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 1.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.2 | 3.6 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 1.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 4.7 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.2 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 4.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 1.4 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.2 | 0.7 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
0.2 | 4.0 | GO:0045008 | depyrimidination(GO:0045008) |
0.2 | 3.5 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.7 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 3.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.7 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 3.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.7 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 7.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.9 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.2 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.7 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
0.2 | 2.4 | GO:0060992 | response to fungicide(GO:0060992) |
0.2 | 0.7 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.2 | 0.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 1.1 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.2 | 0.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.2 | 0.7 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.2 | 6.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.9 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.2 | 1.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 5.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.6 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.2 | 0.6 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.2 | 0.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.2 | 2.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.6 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.2 | 0.6 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.6 | GO:0097187 | dentinogenesis(GO:0097187) |
0.2 | 0.2 | GO:0021678 | third ventricle development(GO:0021678) |
0.2 | 0.8 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.2 | 1.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 2.0 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.2 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 1.2 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.2 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.2 | 1.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 4.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 0.8 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.2 | 0.6 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.2 | 2.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.6 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.2 | 6.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
0.2 | 0.4 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.2 | 0.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.2 | 1.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 2.7 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 2.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.6 | GO:2000349 | negative regulation of CD40 signaling pathway(GO:2000349) |
0.2 | 0.6 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.2 | 0.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 1.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 0.6 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 0.4 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.2 | 0.9 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.2 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 2.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.4 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 1.8 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.2 | 2.0 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 1.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 4.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.9 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.5 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 0.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 2.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.2 | 1.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 1.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.2 | 0.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 1.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.5 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.5 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
0.2 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.2 | 1.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.2 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 1.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 0.7 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 1.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.2 | 1.0 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.2 | 0.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.2 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 0.5 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 1.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 1.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.7 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.2 | 1.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 3.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.2 | 0.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.5 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 3.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.5 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.2 | 2.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.2 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.2 | 3.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.6 | GO:0060744 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.2 | 2.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 2.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 1.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 2.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 4.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0015847 | putrescine transport(GO:0015847) |
0.1 | 0.6 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 1.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 3.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 2.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 1.0 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 1.0 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 1.6 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 1.1 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.7 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.6 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.6 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 1.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 1.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.4 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.1 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 1.4 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
0.1 | 0.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 4.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.1 | GO:0043201 | response to leucine(GO:0043201) |
0.1 | 0.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 6.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 2.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.1 | 4.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 1.5 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.7 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 4.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.7 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 1.7 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.4 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.1 | 1.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.5 | GO:0008291 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:1902805 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 2.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.1 | 2.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.4 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.1 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 2.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.1 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.4 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.6 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 1.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.6 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 1.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 1.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.7 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.8 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 1.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 2.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.2 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
0.1 | 1.2 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.1 | 1.0 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 1.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.7 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 2.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 2.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 1.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 1.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.2 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.1 | 2.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.6 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 1.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 1.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 2.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.3 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 3.0 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 1.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 1.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 1.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 2.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.6 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 2.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.1 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 26.9 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.6 | GO:0061143 | alveolar primary septum development(GO:0061143) pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.7 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 0.9 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.2 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.1 | 0.3 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) primary lung bud formation(GO:0060431) hepatic duct development(GO:0061011) |
0.1 | 0.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.3 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.1 | 0.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 3.8 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.4 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 1.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 16.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 1.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.3 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.1 | 4.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.3 | GO:0098711 | iron ion import into cell(GO:0097459) iron ion import across plasma membrane(GO:0098711) |
0.1 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 2.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 3.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.3 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
0.1 | 0.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 1.9 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 3.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 1.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 1.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.1 | 0.1 | GO:0016114 | diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) |
0.1 | 1.8 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.2 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.6 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.9 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.1 | 0.2 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 3.0 | GO:0090278 | negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
0.1 | 1.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 14.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.8 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.4 | GO:0045007 | depurination(GO:0045007) |
0.1 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.9 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 2.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 1.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.9 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 2.3 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 0.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 1.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 1.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 4.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 3.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0046103 | adenosine catabolic process(GO:0006154) hypoxanthine salvage(GO:0043103) inosine biosynthetic process(GO:0046103) |
0.1 | 2.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 1.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 1.7 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.5 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.2 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.1 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.3 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 2.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 2.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.8 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 1.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.2 | GO:1990451 | cellular stress response to acidic pH(GO:1990451) |
0.1 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.3 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.2 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 1.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.9 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.5 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.7 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 2.8 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.6 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 3.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.2 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) D-xylose metabolic process(GO:0042732) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.1 | 0.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 10.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.2 | GO:2000439 | regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.1 | 4.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.0 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.2 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
0.0 | 0.2 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.0 | 0.1 | GO:0051230 | mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
0.0 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 1.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.5 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.7 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.2 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0071362 | cellular response to ether(GO:0071362) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.2 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 1.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 1.0 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.0 | 1.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.1 | GO:2000542 | negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.0 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 1.9 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.2 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.4 | GO:0048521 | negative regulation of behavior(GO:0048521) negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.7 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 1.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.9 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
0.0 | 1.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 1.0 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.3 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 1.3 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 1.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:0044691 | tooth eruption(GO:0044691) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.9 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.2 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 7.3 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.5 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 1.6 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 2.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.2 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 1.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.9 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.3 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 1.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0061709 | reticulophagy(GO:0061709) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 2.8 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.3 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.1 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.0 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.2 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.1 | GO:0045110 | neurofilament bundle assembly(GO:0033693) intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 1.2 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0014889 | post-chaperonin tubulin folding pathway(GO:0007023) muscle atrophy(GO:0014889) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.3 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.0 | 0.1 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.0 | 0.1 | GO:0097369 | sodium ion import(GO:0097369) positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 1.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.8 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
1.3 | 4.0 | GO:0055028 | cortical microtubule(GO:0055028) |
1.0 | 4.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
1.0 | 2.9 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.0 | 3.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.9 | 4.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 6.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.8 | 2.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.7 | 6.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 2.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.6 | 9.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.9 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.6 | 5.6 | GO:0071546 | pi-body(GO:0071546) |
0.6 | 3.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.6 | 3.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.6 | 3.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.5 | 1.6 | GO:0097179 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) protease inhibitor complex(GO:0097179) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.5 | 1.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.5 | 4.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 2.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 2.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.5 | 8.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 2.3 | GO:0031905 | early endosome lumen(GO:0031905) |
0.5 | 3.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 2.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.4 | 1.7 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.4 | 1.3 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.4 | 2.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 2.1 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 1.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.4 | 2.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.4 | 1.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 4.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 15.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 2.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 1.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.3 | 1.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 3.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 5.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 2.3 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.1 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.3 | 1.1 | GO:0005715 | late recombination nodule(GO:0005715) |
0.3 | 1.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 1.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 3.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.1 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 2.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.0 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 0.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 7.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 5.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 4.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 5.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 3.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 4.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 1.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.2 | 14.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.2 | 1.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 1.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 9.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 15.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 2.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 5.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 2.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 2.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.6 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.7 | GO:1990742 | microvesicle(GO:1990742) |
0.2 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.2 | 4.5 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 2.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.2 | 3.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 0.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 0.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 6.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 12.7 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 6.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 2.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 1.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 2.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 17.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 2.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 4.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.1 | 37.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 3.1 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 8.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 1.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.5 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 6.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 3.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 4.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 2.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.4 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 5.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 5.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 3.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 15.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 0.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0071920 | cleavage body(GO:0071920) |
0.1 | 1.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 12.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 5.3 | GO:0031430 | M band(GO:0031430) |
0.1 | 11.9 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 7.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.2 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.1 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 6.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.2 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.1 | 0.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:1990913 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
0.1 | 2.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 3.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 1.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 3.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 10.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 1.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.8 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 4.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.0 | 1.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 1.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 6.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 19.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 6.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 1.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 3.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 3.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.0 | 0.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.1 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 1.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 1.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 11.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 2.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 4.0 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0035375 | zymogen binding(GO:0035375) |
1.8 | 5.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.7 | 5.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
1.6 | 4.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.6 | 4.7 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
1.5 | 8.9 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.4 | 4.2 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
1.4 | 4.2 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
1.3 | 10.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.3 | 4.0 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
1.0 | 3.1 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.0 | 3.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.0 | 4.1 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
1.0 | 5.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.9 | 2.8 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.9 | 2.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.8 | 4.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 2.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.8 | 3.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.7 | 2.2 | GO:0017129 | triglyceride binding(GO:0017129) |
0.7 | 2.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.7 | 5.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.7 | 10.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 2.1 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
0.7 | 2.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.7 | 2.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.7 | 1.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.7 | 2.7 | GO:0070905 | serine binding(GO:0070905) |
0.7 | 2.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.7 | 10.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 7.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 0.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.6 | 3.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.6 | 4.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.6 | 12.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.6 | 9.8 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.6 | 1.7 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 3.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 3.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.5 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 1.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.5 | 1.6 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.5 | 10.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 2.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 4.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.5 | 2.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 2.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.5 | 3.7 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 3.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 1.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 5.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.8 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.5 | 1.8 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.4 | 2.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 1.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.3 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
0.4 | 13.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.4 | 2.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.4 | 1.3 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.4 | 2.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.4 | 2.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.4 | 5.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.4 | 1.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 1.2 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.4 | 3.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 5.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 2.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 2.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 1.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.4 | 1.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.4 | 1.1 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
0.4 | 1.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.4 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 1.4 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.3 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.3 | 4.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 1.0 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 2.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 2.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 2.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 3.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 1.3 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 1.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 1.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 4.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.3 | 3.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 2.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 5.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.6 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 8.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 2.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 1.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 4.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.8 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 8.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 3.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 1.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.3 | 2.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.3 | 0.9 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.3 | 4.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 4.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.6 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.3 | 2.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 3.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.1 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.3 | 2.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 0.6 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.3 | 0.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.3 | 1.4 | GO:1903135 | cupric ion binding(GO:1903135) |
0.3 | 0.8 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.3 | 0.8 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.3 | 1.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 7.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 1.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 0.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.3 | 11.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 1.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 4.5 | GO:0015923 | mannosidase activity(GO:0015923) |
0.3 | 0.8 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.3 | 0.8 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 2.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 9.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 2.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 3.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 0.8 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
0.3 | 1.5 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.3 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 1.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.3 | 1.0 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.3 | 1.0 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 1.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 1.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 3.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 0.7 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.2 | 1.5 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.2 | 3.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 2.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.9 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
0.2 | 1.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.2 | 0.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.2 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 7.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 4.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 2.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 2.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.2 | 1.1 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.2 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.1 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide insertion or deletion binding(GO:0032139) dinucleotide repeat insertion binding(GO:0032181) |
0.2 | 1.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.6 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 1.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 2.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 5.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.6 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
0.2 | 3.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 4.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.2 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 5.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 3.7 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 3.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.2 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.6 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 3.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 3.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.6 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.2 | 1.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 0.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 0.5 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 0.7 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 1.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 3.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.2 | 0.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.2 | 0.5 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.2 | 2.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 4.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 0.7 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
0.2 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 0.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.7 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.3 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.7 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 3.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 2.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 0.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 3.0 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 1.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.8 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 4.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.3 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 1.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.1 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 1.8 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 2.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 21.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.3 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 2.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.9 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 7.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 2.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 3.3 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
0.1 | 0.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 3.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 1.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.5 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.3 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 2.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 4.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 2.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.1 | 1.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.4 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.3 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 6.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 3.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 3.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 3.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 9.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 0.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.1 | 2.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.1 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 3.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 0.5 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 2.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 3.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 2.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 1.2 | GO:0043295 | glutathione binding(GO:0043295) |
0.1 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 31.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 2.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 2.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 3.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 4.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.2 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
0.1 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 2.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 4.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 2.7 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 1.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 3.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.9 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.3 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0030395 | lactose binding(GO:0030395) |
0.1 | 0.2 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.1 | 0.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 2.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 4.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0004078 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.0 | 1.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 29.7 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 0.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 1.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 1.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 1.9 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.1 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.0 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.0 | 0.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.0 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 3.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 2.7 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 1.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 1.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 1.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 2.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 5.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.1 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
0.0 | 0.1 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
0.0 | 0.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 1.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 1.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.0 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.0 | 0.1 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.0 | 0.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 38.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 1.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 5.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 10.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 5.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 10.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 8.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 9.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 10.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 5.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 7.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 10.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 15.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 6.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 8.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 3.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 5.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 18.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 3.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 4.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 5.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 8.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 3.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 2.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 3.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 6.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 5.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 2.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 2.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 2.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 2.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 2.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 13.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 8.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.4 | 13.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 11.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 1.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 10.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 5.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 9.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 13.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 5.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 26.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 19.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 4.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 4.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 4.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 5.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 9.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 4.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 2.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 3.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 10.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 5.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 5.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 5.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 4.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 3.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 2.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 7.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 3.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 4.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 6.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 3.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 4.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 3.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 14.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 4.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 4.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 5.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 4.8 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 5.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 3.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 3.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 2.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 2.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 3.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 7.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 3.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 2.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 3.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 2.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 2.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 3.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 3.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |